Mitochondria in Neuroplasticity and Neurological Disorders

Neuron

Volumn 60, Issue 5, 2008, Pages 748-766

  Mattson, Mark P ^a   Gleichmann, Marc ^a   Cheng, Aiwu ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN NERVE CELL; CELL MIGRATION; DNA REPLICATION; ELECTRON TRANSPORT; HUMAN; HUNTINGTON CHOREA; MITOCHONDRION; NERVE CELL PLASTICITY; NERVE FIBER DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; STROKE;

ANIMALS; ELECTRON TRANSPORT COMPLEX I; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES; NEURONAL PLASTICITY;

EID: 57049143140     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2008.10.010     Document Type: Review

References (206)

1. Abeliovich A., Schmitz Y., Fariñas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25 (2000) 239-252
2. Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B., Greco T.M., Thomas B., Ko H.S., Sasaki M., Ischiropoulos H., Przedborski S., et al. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. USA 104 (2007) 14807-14812
3. Arthur P.G., Matich G.P., Pang W.W., Yu D.Y., and Bogoyevitch M.A. Necrotic death of neurons following an excitotoxic insult is prevented by a peptide inhibitor of c-jun N-terminal kinase. J. Neurochem. 102 (2007) 65-76
4. Arumugam T.V., Gleichmann M., Tang S.C., and Mattson M.P. Hormesis/ preconditioning mechanisms, the nervous system and aging. Ageing Res. Rev. 5 (2006) 165-178
5. Atsumi T. The ultrastructure of intramuscular nerves in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.) 55 (1981) 193-198
6. Bae B.I., Xu H., Igarashi S., Fujimuro M., Agrawal N., Taya Y., Hayward S.D., Moran T.H., Montell C., Ross C.A., et al. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47 (2005) 29-41
7. Barsoum M.J., Yuan H., Gerencser A.A., Liot G., Kushnareva Y., Gräber S., Kovacs I., Lee W.D., Waggoner J., Cui J., et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 25 (2006) 3900-3911
8. Beal M.F. Bioenergetic approaches for neuroprotection in Parkinson's disease. Ann. Neurol. 53 Suppl 3 (2003) S39-S47
9. Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., and Brown Jr. R.H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42 (1997) 644-654
10. Berman S.B., Pineda F.J., and Hardwick J.M. Mitochondrial fission and fusion dynamics: the long and short of it. Cell Death Differ. 15 (2008) 1147-1152
11. Bezprozvanny I., and Mattson M.P. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 31 (2008) 454-463
12. Billups B., and Forsythe I.D. Presynaptic mitochondrial calcium sequestration influences transmission at mammalian central synapses. J. Neurosci. 22 (2002) 5840-5847
13. Bindokas V.P., Lee C.C., Colmers W.F., and Miller R.J. Changes in mitochondrial function resulting from synaptic activity in the rat hippocampal slice. J. Neurosci. 18 (1998) 4570-4587
14. Binet S., and Meininger V. Modifications of microtubule proteins in ALS nerve precede detectable histologic and ultrastructural changes. Neurology 38 (1988) 1596-1600
15. Biskup S., and Moore D.J. Detrimental deletions: mitochondria, aging and Parkinson's disease. Bioessays 28 (2006) 963-967
16. Bogaerts V., Theuns J., and van Broeckhoven C. Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?. Genes Brain Behav. 7 (2008) 129-151
17. Boillée S., Vande Velde C., and Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52 (2006) 39-59
18. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24 (2003) 197-211
19. Bromberg M.B. Diagnostic criteria and outcome measurement of amyotrophic lateral sclerosis. Adv. Neurol. 88 (2002) 53-62
20. Brouillet E., Jacquard C., Bizat N., and Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J. Neurochem. 95 (2005) 1521-1540
21. Bruce-Keller A.J., Li Y.J., Lovell M.A., Kraemer P.J., Gary D.S., Brown R.R., Markesbery W.R., and Mattson M.P. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J. Neuropathol. Exp. Neurol. 57 (1998) 257-267
22. Burkhalter J., Fiumelli H., Allaman I., Chatton J.Y., and Martin J.L. Brain-derived neurotrophic factor stimulates energy metabolism in developing cortical neurons. J. Neurosci. 23 (2003) 8212-8220
23. Cai H., Lin X., Xie C., Laird F.M., Lai C., Wen H., Chiang H.C., Shim H., Farah M.H., Hoke A., et al. Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J. Neurosci. 25 (2005) 7567-7574
24. Cameron H.A., Kaliszewski C.K., and Greer C.A. Organization of mitochondria in olfactory bulb granule cell dendritic spines. Synapse 8 (1991) 107-118
25. Canet-Avilés R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., and Cookson M.R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. USA 101 (2004) 9103-9108
26. Cassina P., Cassina A., Pehar M., Castellanos R., Gandelman M., de León A., Robinson K.M., Mason R.P., Beckman J.S., Barbeito L., and Radi R. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J. Neurosci. 28 (2008) 4115-4122
27. Chada S.R., and Hollenbeck P.J. Nerve growth factor signaling regulates motility and docking of axonal mitochondria. Curr. Biol. 14 (2004) 1272-1276
28. Chan S.L., Liu D., Kyriazis G.A., Bagsiyao P., Ouyang X., and Mattson M.P. Mitochondrial uncoupling protein-4 regulates calcium homeostasis and sensitivity to store depletion-induced apoptosis in neural cells. J. Biol. Chem. 281 (2006) 37391-37403
29. Chang D.T., and Reynolds I.J. Differences in mitochondrial movement and morphology in young and mature primary cortical neurons in culture. Neuroscience 141 (2006) 727-736
30. Chang D.T., Rintoul G.L., Pandipati S., and Reynolds I.J. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol. Dis. 22 (2006) 388-400
31. Chang M.Y., Sun W., Ochiai W., Nakashima K., Kim S.Y., Park C.H., Kang J.S., Shim J.W., Jo A.Y., Kang C.S., et al. Bcl-XL/Bax proteins direct the fate of embryonic cortical precursor cells. Mol. Cell. Biol. 27 (2007) 4293-4305
32. Cheng A., Wang S., Cai J., Rao M.S., and Mattson M.P. Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev. Biol. 258 (2003) 319-333
33. Cheng A., Arumugam T.V., Liu D., Khatri R.G., Mustafa K., Kwak S., Ling H.P., Gonzales C., Xin O., Jo D.G., et al. Pancortin-2 interacts with WAVE1 and Bcl-xL in a mitochondria-associated protein complex that mediates ischemic neuronal death. J. Neurosci. 27 (2007) 1519-1528
34. Cheung E.C., Joza N., Steenaart N.A., McClellan K.A., Neuspiel M., McNamara S., MacLaurin J.G., Rippstein P., Park D.S., Shore G.C., et al. Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J. 25 (2006) 4061-4073
35. Choo Y.S., Johnson G.V., MacDonald M., Detloff P.J., and Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 13 (2004) 1407-1420
36. Clark I.E., Dodson M.W., Jiang C., Cao J.H., Huh J.R., Seol J.H., Yoo S.J., Hay B.A., and Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441 (2006) 1162-1166
37. Cui L., Jeong H., Borovecki F., Parkhurst C.N., Tanese N., and Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127 (2006) 59-69
38. Culmsee C., and Mattson M.P. p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun. 331 (2005) 761-777
39. Cutler R.G., Pedersen W.A., Camandola S., Rothstein J.D., and Mattson M.P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 52 (2002) 448-457
40. Cutler R.G., Kelly J., Storie K., Pedersen W.A., Tammara A., Hatanpaa K., Troncoso J.C., and Mattson M.P. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101 (2004) 2070-2075
41. Darios F., Corti O., Lücking C.B., Hampe C., Muriel M.P., Abbas N., Gu W.J., Hirsch E.C., Rooney T., Ruberg M., and Brice A. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. 12 (2003) 517-526
42. Darios F., Muriel M.P., Khondiker M.E., Brice A., and Ruberg M. Neurotoxic calcium transfer from endoplasmic reticulum to mitochondria is regulated by cyclin-dependent kinase 5-dependent phosphorylation of tau. J. Neurosci. 25 (2005) 4159-4168
43. Detmer S.A., and Chan D.C. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J. Cell Biol. 176 (2007) 405-414
44. De Vos K.J., Chapman A.L., Tennant M.E., Manser C., Tudor E.L., Lau K.F., Brownlees J., Ackerley S., Shaw P.J., McLoughlin D.M., et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 16 (2007) 2720-2728
45. Devi L., Raghavendran V., Prabhu B.M., Avadhani N.G., and Anandatheerthavarada H.K. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283 (2008) 9089-9100
46. DiFiglia M., Sena-Esteves M., Chase K., Sapp E., Pfister E., Sass M., Yoder J., Reeves P., Pandey R.K., Rajeev K.G., et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl. Acad. Sci. USA 104 (2007) 17204-17209
47. Duan W., Rangnekar V.M., and Mattson M.P. Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J. Neurochem. 72 (1999) 2312-2322
48. Duan W., Guo Z., Jiang H., Ladenheim B., Xu X., Cadet J.L., and Mattson M.P. Paroxetine retards disease onset and progression in Huntingtin mutant mice. Ann. Neurol. 55 (2004) 590-594
49. Dyall S.D., Brown M.T., and Johnson P.J. Ancient invasions: from endosymbionts to organelles. Science 304 (2004) 253-257
50. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., and Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391 (1998) 43-50
51. Endo H., Kamada H., Nito C., Nishi T., and Chan P.H. Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. J. Neurosci. 26 (2006) 7974-7983
52. Erecinska M., Cherian S., and Silver I.A. Energy metabolism in mammalian brain during development. Prog. Neurobiol. 73 (2004) 397-445
53. Esposito L., Raber J., Kekonius L., Yan F., Yu G.Q., Bien-Ly N., Puoliväli J., Scearce-Levie K., Masliah E., and Mucke L. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci. 26 (2006) 5167-5179
54. Exner N., Treske B., Paquet D., Holmström K., Schiesling C., Gispert S., Carballo-Carbajal I., Berg D., Hoepken H.H., and Gasser T. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J. Neurosci. 27 (2007) 12413-12418
55. Fattal O., Budur K., Vaughan A.J., and Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 47 (2006) 1-7
56. Fernandes H.B., Baimbridge K.G., Church J., Hayden M.R., and Raymond L.A. Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease. J. Neurosci. 27 (2007) 13614-13623
57. Ferrante R.J., Kubilus J.K., Lee J., Ryu H., Beesen A., Zucker B., Smith K., Kowall N.W., Ratan R.R., Luthi-Carter R., and Hersch S.M. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 23 (2003) 9418-9427
58. Ferri A., Cozzolino M., Crosio C., Nencini M., Casciati A., Gralla E.B., Rotilio G., Valentine J.S., and Carrì M.T. Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc. Natl. Acad. Sci. USA 103 (2006) 13860-13865
59. Frederick R.L., and Shaw J.M. Moving mitochondria: establishing distribution of an essential organelle. Traffic 8 (2007) 1668-1675
60. Friberg H., Ferrand-Drake M., Bengtsson F., Halestrap A.P., and Wieloch T. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J. Neurosci. 18 (1998) 5151-5159
61. Fukui H., Diaz F., Garcia S., and Moraes C.T. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 104 (2007) 14163-14168
62. Gardner A., Johansson A., Wibom R., Nennesmo I., von Döbeln U., Hagenfeldt L., and Hällström T. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J. Affect. Disord. 76 (2003) 55-68
63. Gerlach M., Riederer P., Przuntek H., and Youdim M.B. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur. J. Pharmacol. 208 (1991) 273-286
64. Giacomello M., Drago I., Pizzo P., and Pozzan T. Mitochondrial Ca2+ as a key regulator of cell life and death. Cell Death Differ. 14 (2007) 1267-1274
65. Glazner G.W., Chan S.L., Lu C., and Mattson M.P. Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis. J. Neurosci. 20 (2000) 3641-3649
66. Goedert M., and Spillantini M.G. A century of Alzheimer's disease. Science 314 (2006) 777-781
67. Goldstein S., and Merenyi G. The chemistry of peroxynitrite: implications for biological activity. Methods Enzymol. 436 (2008) 49-61
68. Gould T.W., Buss R.R., Vinsant S., Prevette D., Sun W., Knudson C.M., Milligan C.E., and Oppenheim R.W. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26 (2006) 8774-8786
69. Greene J.C., Whitworth A.J., Kuo I., Andrews L.A., Feany M.B., and Pallanck L.J. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. USA 100 (2003) 4078-4083
70. Gros-Louis F., Gaspar C., and Rouleau G.A. Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762 (2006) 956-972
71. Gulyaeva N.V., Kudryashov I.E., and Kudryashova I.V. Caspase activity is essential for long-term potentiation. J. Neurosci. Res. 73 (2003) 853-864
72. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W., et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94 (1998) 339-352
73. Hansson C.A., Frykman S., Farmery M.R., Tjernberg L.O., Nilsberth C., Pursglove S.E., Ito A., Winblad B., Cowburn R.F., Thyberg J., and Ankarcrona M. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J. Biol. Chem. 279 (2004) 51654-51660
74. Hao Z., Duncan G.S., Chang C.C., Elia A., Fang M., Wakeham A., Okada H., Calzascia T., Jang Y., You-Ten A., et al. Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell 121 (2005) 579-591
75. Hardy J. A hundred years of Alzheimer's disease research. Neuron 52 (2006) 3-13
76. Harms K.J., Rioult-Pedotti M.S., Carter D.R., and Dunaevsky A. Transient spine expansion and learning-induced plasticity in layer 1 primary motor cortex. J. Neurosci. 28 (2008) 5686-5690
77. Hashimoto M., Rockenstein E., Crews L., and Masliah E. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Neuromolecular Med. 4 (2003) 21-36
78. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., et al. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21 (2001) 3017-3023
79. Hollenbeck P.J., and Saxton W.M. The axonal transport of mitochondria. J. Cell Sci. 118 (2005) 5411-5419
80. Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., Wong J., Takenouchi T., Hashimoto M., and Masliah E. alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157 (2000) 401-410
81. Huang X., Zhai D., and Huang Y. Dependence of permeability transition pore opening and cytochrome C release from mitochondria on mitochondria energetic status. Mol. Cell. Biochem. 224 (2001) 1-7
82. Huesmann G.R., and Clayton D.F. Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation. Neuron 52 (2006) 1061-1072
83. Iwamoto K., Bundo M., and Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 14 (2005) 241-253
84. Juhaszova M., Wang S., Zorov D.B., Nuss H.B., Gleichmann M., Mattson M.P., and Sollott S.J. The identity and regulation of the mitochondrial permeability transition pore: where the known meets the unknown. Ann. N Y Acad. Sci. 1123 (2008) 197-212
85. Kang J.-S., Tian J.-H., Pan P.-Y., Zald P., Li C., Deng C., and Sheng Z.-H. Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. Cell 132 (2008) 137-148
86. Karbowski M., Jeong S.Y., and Youle R.J. Endophilin B1 is required for the maintenance of mitochondrial morphology. J. Cell Biol. 166 (2004) 1027-1039
87. Kato T. Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 21 (2007) 1-11
88. Kato S. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol. (Berl.) 115 (2008) 97-114
89. Keeney P.M., Xie J., Capaldi R.A., and Bennett Jr. J.P. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 26 (2006) 5256-5264
90. Keep M., Elmér E., Fong K.S., and Csiszar K. Intrathecal cyclosporin prolongs survival of late-stage ALS mice. Brain Res. 894 (2001) 327-331
91. Keller J.N., Mark R.J., Bruce A.J., Blanc E., Rothstein J.D., Uchida K., Waeg G., and Mattson M.P. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80 (1997) 685-696
92. Keller J.N., Kindy M.S., Holtsberg F.W., St Clair D.K., Yen H.C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., and Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18 (1998) 687-697
93. Kirkland R.A., and Franklin J.L. Bax, reactive oxygen, and cytochrome c release in neuronal apoptosis. Antioxid. Redox Signal. 5 (2003) 589-596
94. Kishida K.T., and Klann E. Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxid. Redox Signal. 9 (2007) 233-244
95. Klivenyi P., Ferrante R.J., Matthews R.T., Bogdanov M.B., Klein A.M., Andreassen O.A., Mueller G., Wermer M., Kaddurah-Daouk R., and Beal M.F. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5 (1999) 347-350
96. Kong J., and Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18 (1998) 3241-3250
97. Korde A.S., Pettigrew L.C., Craddock S.D., and Maragos W.F. The mitochondrial uncoupler 2,4-dinitrophenol attenuates tissue damage and improves mitochondrial homeostasis following transient focal cerebral ischemia. J. Neurochem. 94 (2005) 1676-1684
98. Korde A.S., Pettigrew L.C., Craddock S.D., Pocernich C.B., Waldmeier P.C., and Maragos W.F. Protective effects of NIM811 in transient focal cerebral ischemia suggest involvement of the mitochondrial permeability transition. J. Neurotrauma 24 (2007) 895-908
99. Koshiba T., Detmer S.A., Kaiser J.T., Chen H., McCaffery J.M., and Chan D.C. Structural basis of mitochondrial tethering by mitofusin complexes. Science 305 (2004) 858-862
100. Kruman I.I., Pedersen W.A., Springer J.E., and Mattson M.P. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp. Neurol. 160 (1999) 28-39
101. Kuida K., Zheng T.S., Na S., Kuan C., Yang D., Karasuyama H., Rakic P., and Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384 (1996) 368-372
102. Leonard J.R., Klocke B.J., D'Sa C., Flavell R.A., and Roth K.A. Strain-dependent neurodevelopmental abnormalities in caspase-3-deficient mice. J. Neuropathol. Exp. Neurol. 61 (2002) 673-677
103. Levy M., Faas G.C., Saggau P., Craigen W.J., and Sweatt J.D. Mitochondrial regulation of synaptic plasticity in the hippocampus. J. Biol. Chem. 278 (2003) 17727-17734
104. Li Z., Okamoto K.-I., Hayashi Y., and Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119 (2004) 873-887
105. Lindsten T., Ross A.J., King A., Zong W.X., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6 (2000) 1389-1399
106. Liu Q.A., and Shio H. Mitochondrial morphogenesis, dendrite development, and synapse formation in cerebellum require both Bcl-w and the glutamate receptor delta2. PLoS Genet. 4 (2008) e1000097
107. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., Cotman C.W., and Ames B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-α-lipoic acid. Proc. Natl. Acad. Sci. USA 99 (2002) 2356-2361
108. Liu D., Lu C., Wan R., Auyeung W.W., and Mattson M.P. Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J. Cereb. Blood Flow Metab. 22 (2002) 431-443
109. Liu D., Chan S.L., de Souza-Pinto N.C., Slevin J.R., Wersto R.P., Zhan M., Mustafa K., de Cabo R., and Mattson M.P. Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. Neuromolecular Med. 8 (2006) 389-414
110. Lu C., Fu W., Salvesen G.S., and Mattson M.P. Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. Neuromolecular Med. 1 (2002) 69-79
111. Lu C., Wang Y., Furukawa K., Fu W., Ouyang X., and Mattson M.P. Evidence that caspase-1 is a negative regulator of AMPA receptor-mediated long-term potentiation at hippocampal synapses. J. Neurochem. 97 (2006) 1104-1110
112. Lu Y., Christian K., and Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory?. Neurobiol. Learn. Mem. 89 (2008) 312-323
113. Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N., Caspersen C., Chen X., Pollak S., Chaney M., et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304 (2004) 448-452
114. Manczak M., Anekonda T.S., Henson E., Park B.S., Quinn J., and Reddy P.H. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15 (2006) 1437-1449
115. Manetto V., Sternberger N.H., Perry G., Sternberger L.A., and Gambetti P. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 47 (1988) 642-653
116. Markham A., Cameron I., Franklin P., and Spedding M. BDNF increases rat brain mitochondrial respiratory coupling at complex I, but not complex II. Eur. J. Neurosci. 20 (2004) 1189-1196
117. Martin L.J., Pan Y., Price A.C., Sterling W., Copeland N.G., Jenkins N.A., Price D.L., and Lee M.K. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26 (2006) 41-50
118. Martins L.M., Morrison A., Klupsch K., Fedele V., Moisoi N., Teismann P., Abuin A., Grau E., Geppert M., Livi G.P., et al. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell. Biol. 24 (2004) 9848-9862
119. Masuda N., Peng Q., Li Q., Jiang M., Liang Y., Wang X., Zhao M., Wang W., Ross C.A., and Duan W. Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease. Neurobiol. Dis. 30 (2008) 293-302
120. Mattiasson G., Shamloo M., Gido G., Mathi K., Tomasevic G., Yi S., Warden C.H., Castilho R.F., Melcher T., Gonzalez-Zulueta M., et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat. Med. 9 (2003) 1062-1068
121. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
122. Mattson M.P., and Partin J. Evidence for mitochondrial control of neuronal polarity. J. Neurosci. Res. 56 (1999) 8-20
123. Mattson M.P., and Cheng A. Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci. 29 (2006) 632-639
124. Mattson M.P., Keller J.N., and Begley J.G. Evidence for synaptic apoptosis. Exp. Neurol. 153 (1998) 35-48
125. Mattson M.P., Maudsley S., and Martin B. A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Res. Rev. 3 (2004) 445-464
126. Maurer I., Zierz S., and Möller H.J. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol. Aging 21 (2000) 455-462
127. Milakovic T., Quintanilla R.A., and Johnson G.V. Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences. J. Biol. Chem. 281 (2006) 34785-34795
128. Miller K.E., and Sheetz M.P. Axonal mitochondrial transport and potential are correlated. J. Cell Sci. 117 (2004) 2791-2804
129. Miller T.M., Moulder K.L., Knudson C.M., Creedon D.J., Deshmukh M., Korsmeyer S.J., and Johnson Jr. E.M. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell Biol. 139 (1997) 205-217
130. Miyawaki T., Mashiko T., Ofengeim D., Flannery R.J., Noh K.M., Fujisawa S., Bonanni L., Bennett M.V., Zukin R.S., and Jonas E.A. Ischemic preconditioning blocks BAD translocation, Bcl-xL cleavage, and large channel activity in mitochondria of postischemic hippocampal neurons. Proc. Natl. Acad. Sci. USA 105 (2008) 4892-4897
131. Moore D.J., Zhang L., Troncoso J., Lee M.K., Hattori N., Mizuno Y., Dawson T.M., and Dawson V.L. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum. Mol. Genet. 14 (2005) 71-84
132. Moreira P.I., Siedlak S.L., Wang X., Santos M.S., Oliveira C.R., Tabaton M., Nunomura A., Szweda L.I., Aliev G., Smith M.A., et al. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 3 (2007) 614-615
133. Mosconi L., De Santi S., Li J., Tsui W.H., Li Y., Boppana M., Laska E., Rusinek H., and de Leon M.J. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol. Aging 29 (2008) 676-692
134. Moustafa R.R., and Baron J.C. Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. Br. J. Pharmacol. 153 Suppl 1 (2008) S44-S54
135. Murphy A.N., Bredesen D.E., Cortopassi G., Wang E., and Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl. Acad. Sci. USA 93 (1996) 9893-9898
136. Nicholls D.G., Vesce S., Kirk L., and Chalmers S. Interactions between mitochondrial bioenergetics and cytoplasmic calcium in cultured cerebellar granule cells. Cell Calcium 34 (2003) 407-424
137. Nieminen A.L. Apoptosis and necrosis in health and disease: role of mitochondria. Int. Rev. Cytol. 224 (2003) 29-55
138. Onishi H., Kawanishi C., Iwasawa T., Osaka H., Hanihara T., Inoue K., Yamada Y., and Kosaka K. Depressive disorder due to mitochondrial transfer RNALeu(UUR) mutation. Biol. Psychiatry 41 (1997) 1137-1139
139. Orr A.L., Li S., Wang C.E., Li H., Wang J., Rong J., Xu X., Mastroberardino P.G., Greenamyre J.T., and Li X.J. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J. Neurosci. 28 (2008) 2783-2792
140. Overly C.C., Rieff H.I., and Hollenbeck P.J. Organelle motility and metabolism in axons vs dendrites of cultured hippocampal neurons. J. Cell Sci. 109 (1996) 971-980
141. Palacino J.J., Sagi D., Goldberg M.S., Krauss S., Motz C., Wacker M., Klose J., and Shen J. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279 (2004) 18614-18622
142. Panov A.V., Gutekunst C.A., Leavitt B.R., Hayden M.R., Burke J.R., Strittmatter W.J., and Greenamyre J.T. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5 (2002) 731-736
143. Park J., Kim S.Y., Cha G.H., Lee S.B., Kim S., and Chung J. Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361 (2005) 133-139
144. Park H.J., Kim S.S., Seong Y.M., Kim K.H., Goo H.G., Yoon E.J., Min do S., Kang S., and Rhim H. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. J. Biol. Chem. 281 (2006) 34277-34287
145. Park J., Lee S.B., Lee S., Kim Y., Song S., Kim S., Bae E., Kim J., Shong M., Kim J.M., and Chung J. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441 (2006) 1157-1161
146. Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., and Brown Jr. R.H. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43 (2004) 19-30
147. Pedersen W.A., Fu W., Keller J.N., Markesbery W.R., Appel S., Smith R.G., Kasarskis E., and Mattson M.P. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 44 (1998) 819-824
148. Perez Velazquez J.L., Frantseva M.V., Huzar D.V., and Carlen P.L. Mitochondrial porin required for ischemia-induced mitochondrial dysfunction and neuronal damage. Neuroscience 97 (2000) 363-369
149. Pigino G., Morfini G., Pelsman A., Mattson M.P., Brady S.T., and Busciglio J. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 23 (2003) 4499-4508
150. Plesnila N., Zinkel S., Le D.A., Amin-Hanjani S., Wu Y., Qiu J., Chiarugi A., Thomas S.S., Kohane D.S., Korsmeyer S.J., and Moskowitz M.A. BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 98 (2001) 15318-15323
151. Poole A.C., Thomas R.E., Andrews L.A., McBride H.M., Whitworth A.J., and Pallanck L.J. The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl. Acad. Sci. USA 105 (2008) 1638-1643
152. Poon H.F., Frasier M., Shreve N., Calabrese V., Wolozin B., and Butterfield D.A. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice-a model of familial Parkinson's disease. Neurobiol. Dis. 18 (2005) 492-498
153. Pridgeon J.W., Olzmann J.A., Chin L.S., and Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 5 (2007) e172
154. Prince J.A., Harro J., Blennow K., Gottfries C.G., and Oreland L. Putamen mitochondrial energy metabolism is highly correlated to emotional an intellectuarl impairment in schizophrenics. Neuropsychopharmacology 22 (2000) 284-292
155. Rice S.E., and Gelfand V.I. Paradigm lost: milton connects kinesin heavy chain to miro on mitochondria. J. Cell Biol. 173 (2006) 459-461
156. Riedl S.J., and Salvesen G.S. The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell Biol. 8 (2007) 405-413
157. Rogawski M.A. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14 (1993) 325-331
158. Rothstein J.D. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin. Neurosci. 3 (1995) 348-359
159. Ruthel G., and Hollenbeck P.J. Response of mitochondrial traffic to axon determination and differential branch growth. J. Neurosci. 23 (2003) 8618-8624
160. Saha A.R., Ninkina N.N., Hanger D.P., Anderton B.H., Davies A.M., and Buchman V.L. Induction of neuronal death by alpha-synuclein. Eur. J. Neurosci. 12 (2000) 3073-3077
161. Sathasivam S., Ince P.G., and Shaw P.J. Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol. Appl. Neurobiol. 27 (2001) 257-274
162. Schapira A.H. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 7 (2008) 97-109
163. Schinzel A.C., Takeuchi O., Huang Z., Fisher J.K., Zhou Z., Rubens J., Hetz C., Danial N.N., Moskowitz M.A., and Korsmeyer S.J. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 102 (2005) 12005-12010
164. Shao L., Martin M.V., Watson S.J., Schatzberg A., Akil H., Myers R.M., Jones E.G., Bunney W.E., and Vawter M.P. Mitochondrial involvement in psychiatric disorders. Ann. Med. 40 (2008) 281-295
165. Shaw J.M., and Nunnari J. Mitochondrial dynamics and division in budding yeast. Trends Cell Biol. 12 (2002) 178-184
166. Shinkai T., Nakashima M., Ohmori O., Terao T., Nakamura J., Hiramatsu N., Hashiguchi H., and Tsuji S. Coenzyme Q10 improves psychiatric symptoms in adult-onset mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a case report. Aust. N. Z. J. Psychiatry 34 (2000) 1034-1035
167. Shuttleworth C.W., Brennan A.M., and Connor J.A. NAD(P)H fluorescence imaging of postsynaptic neuronal activation in murine hippocampal slices. J. Neurosci. 23 (2003) 3196-3208
168. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
169. Son M., Puttaparthi K., Kawamata H., Rajendran B., Boyer P.J., Manfredi G., and Elliott J.L. Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proc. Natl. Acad. Sci. USA 104 (2007) 6072-6077
170. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319 (2008) 1668-1672
171. Stefanis L. Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury. Neuroscientist 11 (2005) 50-62
172. Stichel C.C., Zhu X.R., Bader V., Linnartz B., Schmidt S., and Lübbert H. Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. Hum. Mol. Genet. 16 (2007) 2377-2393
173. Stoica B.A., Movsesyan V.A., Lea P.M., and Faden A.I. Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway. Mol. Cell. Neurosci. 22 (2003) 365-382
174. Stowers R.S., Megeath L.J., Gorska-Andrzejak J., Meinertzhagen I.A., and Schwarz T.L. Axonal transport of mitochondria to synapses depends on Milton, a novel drosophila protein. Neuron 36 (2002) 1063-1077
175. Swerdlow R.H., Parks J.K., Miller S.W., Tuttle J.B., Trimmer P.A., Sheehan J.P., Bennett Jr. J.P., Davis R.E., and Parker Jr. W.D. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40 (1996) 663-671
176. Swerdlow R.H., Parks J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett Jr. J.P., Davis R.E., and Parker Jr. W.D. Cybrids in Alzheimer's disease: a cellular model of the disease?. Neurology 49 (1997) 918-925
177. Tanaka Y., Engelender S., Igarashi S., Rao R.K., Wanner T., Tanzi R.E., Sawa A., Dawson V.L., Dawson T.M., and Ross C.A. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum. Mol. Genet. 10 (2001) 919-926
178. Tang Y.-G., and Zucker R.S. Mitochondrial involvement in post-tetanic potentiation of synaptic transmission. Neuron 18 (1997) 483-491
179. Tondera D., Czauderna F., Paulick K., Schwarzer R., Kaufmann J., and Santel A. The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells. J. Cell Sci. 118 (2005) 3049-3059
180. Toresson H., and Grant S.G. Dynamic distribution of endoplasmic reticulum in hippocampal neuron dendritic spines. Eur. J. Neurosci. 22 (2005) 1793-1798
181. Twig G., Hyde B., and Shirihai O.S. Mitochondrial fusion, fission and autophagy as a quality control axis: The bioenergetic view. Biochim. Biophys. Acta 1777 (2008) 1092-1097
182. Vande Velde C., Miller T.M., Cashman N.R., and Cleveland D.W. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc. Natl. Acad. Sci. USA 105 (2008) 4022-4027
183. Vayssière J.L., Cordeau-Lossouarn L., Larcher J.C., Basseville M., Gros F., and Croizat B. Participation of the mitochondrial genome in the differentiation of neuroblastoma cells. In Vitro Cell. Dev. Biol. 28A (1992) 763-772
184. Ved R., Saha S., Westlund B., Perier C., Burnam L., Sluder A., Hoener M., Rodrigues C.M., Alfonso A., Steer C., et al. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J. Biol. Chem. 280 (2005) 42655-42668
185. Veereshwarayya V., Kumar P., Rosen K.M., Mestril R., and Querfurth H.W. Differential effects of mitochondrial heat shock protein 60 and related molecular chaperones to prevent intracellular beta-amyloid-induced inhibition of complex IV and limit apoptosis. J. Biol. Chem. 281 (2006) 29468-29478
186. Verstreken P., Ly C.V., Venken J.T.K., Koh T.-W., Zhou Y., and Bellen H.J. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at drosophila neuromuscular junctions. Neuron 47 (2005) 365-378
187. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr. Scand. 101 (2000) 11-20
188. von Lewinski F., and Keller B.U. Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS. Trends Neurosci. 28 (2005) 494-500
189. Walker F.O. Huntington's disease. Lancet 369 (2007) 218-228
190. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39 (2005) 359-407
191. Wang H., Yu S.W., Koh D.W., Lew J., Coombs C., Bowers W., Federoff H.J., Poirier G.G., Dawson T.M., and Dawson V.L. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J. Neurosci. 24 (2004) 10963-10973
192. Wang H., Guan Y., Wang X., Smith K., Cormier K., Zhu S., Stavrovskaya I.G., Huo C., Ferrante R.J., Kristal B.S., and Friedlander R.M. Nortriptyline delays disease onset in models of chronic neurodegeneration. Eur. J. Neurosci. 26 (2007) 633-641
193. Wang W., Groom L., Cheng A., Yin J., Mattson M.P., Kao J.P.Y., Lakatta E.G., Sheu S.S., Dirksen R.T., and Cheng H. Redox flashes in single mitochondria. Cell 134 (2008) 279-290
194. Weydt P., Pineda V.V., Torrence A.E., Libby R.T., Satterfield T.F., Lazarowski E.R., Gilbert M.L., Morton G.J., Bammler T.K., Strand A.D., et al. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab. 4 (2006) 349-362
195. Widdowson P.S., Gyte A., Upton R., Foster J., Coutts C.T., and Wyatt I. Calpain activation and not oxidative damage mediates L-2-chloropropionic acid-induced cerebellar granule cell necrosis. Toxicol. Appl. Pharmacol. 142 (1997) 248-255
196. Yang Y., Gehrke S., Imai Y., Huang Z., Ouyang Y., Wang J.W., Yang L., Beal M.F., Vogel H., and Lu B. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. USA 103 (2006) 10793-10798
197. Yang Y., Ouyang Y., Yang L., Beal M.F., McQuibban A., Vogel H., and Lu B. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc. Natl. Acad. Sci. USA 105 (2008) 7070-7075
198. Yin X.M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B., Roth K.A., and Korsmeyer S.J. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400 (1999) 886-891
199. Yoshida H., Kong Y.Y., Yoshida R., Elia A.J., Hakem A., Hakem R., Penninger J.M., and Mak T.W. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94 (1998) 739-750
200. Yu Z.F., and Mattson M.P. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 57 (1999) 830-839
201. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., Poirier G.G., Dawson T.M., and Dawson V.L. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297 (2002) 259-263
202. Yu S.W., Andrabi S.A., Wang H., Kim N.S., Poirier G.G., Dawson T.M., and Dawson V.L. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl. Acad. Sci. USA 103 (2006) 18314-18319
203. Zhang Y., and Lipton P. Cytosolic Ca2+ changes during in vitro ischemia in rat hippocampal slices: major roles for glutamate and Na+-dependent Ca2+ release from mitochondria. J. Neurosci. 19 (1999) 3307-3315
204. Zhang L., Shimoji M., Thomas B., Moore D.J., Yu S.W., Marupudi N.I., Torp R., Torgner I.A., Ottersen O.P., Dawson T.M., and Dawson V.L. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum. Mol. Genet. 14 (2005) 2063-2073
205. Zheng Z., Lee J.E., and Yenari M.A. Stroke: molecular mechanisms and potential targets for treatment. Curr. Mol. Med. 3 (2003) 361-372
206. Zhu X., Yu Q.S., Cutler R.G., Culmsee C.W., Holloway H.W., Lahiri D.K., Mattson M.P., and Greig N.H. Novel p53 inactivators with neuroprotective action: syntheses and pharmacological evaluation of 2-imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-imino-2,3,4,5,6,7-hexahydrobenzoxazole derivatives. J. Med. Chem. 45 (2002) 5090-5097